Page last updated: 2024-08-26

bismuth and Colitis, Lymphocytic

bismuth has been researched along with Colitis, Lymphocytic in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al Yatama, N; Bhanji, T; Chande, N; MacDonald, JK; McDonald, JW; Nguyen, TM	1
Alpert, L; Colussi, D; Khalili, H; Lauwers, GY; Misdraji, J; Setia, N; Stewart, KO; van der Sloot, KW	1
Chan, AT; Colussi, D; Khalili, H; Lauwers, GY; Ricciardiello, L; Richter, JR; Salari, B; Stewart, KO	1
Dijkstra, G; Karrenbeld, A; Kleibeuker, JH; van der Wouden, EJ	1
Chande, N; Macdonald, JK; McDonald, JW	2

Reviews

4 review(s) available for bismuth and Colitis, Lymphocytic

Article	Year
Interventions for treating lymphocytic colitis. The Cochrane database of systematic reviews, 2017, 07-13, Volume: 7 Topics: Anti-Inflammatory Agents; Antidiarrheals; Beclomethasone; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates	2017
Microscopic colitis: an unfamiliar but treatable disease. The Netherlands journal of medicine, 2009, Volume: 67, Issue:2 Topics: Adult; Antacids; Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Female; Humans; Male	2009
Interventions for treating lymphocytic colitis. The Cochrane database of systematic reviews, 2007, Jan-24, Issue:1 Topics: Antidiarrheals; Bismuth; Colitis, Lymphocytic; Humans; Organometallic Compounds; Salicylates	2007
Interventions for treating lymphocytic colitis. The Cochrane database of systematic reviews, 2008, Apr-16, Issue:2 Topics: Antidiarrheals; Bismuth; Budesonide; Cholestyramine Resin; Colitis, Lymphocytic; Humans; Mesalamine; Organometallic Compounds; Randomized Controlled Trials as Topic; Salicylates	2008

Other Studies

2 other study(ies) available for bismuth and Colitis, Lymphocytic

Article	Year
Lymphocytic colitis: pathologic predictors of response to therapy. Human pathology, 2018, Volume: 78 Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Biopsy; Bismuth; Colitis, Lymphocytic; Collagen; Female; Humans; Male; Mesalamine; Middle Aged; Organometallic Compounds; Salicylates; Steroids; Treatment Outcome	2018
Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis. Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:11 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Female; Humans; Logistic Models; Male; Middle Aged; Organometallic Compounds; Salicylates; Tertiary Care Centers; Treatment Outcome	2015

Article

Year

Lymphocytic colitis: pathologic predictors of response to therapy.

Human pathology, 2018, Volume: 78

Topics: Adult; Aged; Aged, 80 and over; Antidiarrheals; Biopsy; Bismuth; Colitis, Lymphocytic; Collagen; Female; Humans; Male; Mesalamine; Middle Aged; Organometallic Compounds; Salicylates; Steroids; Treatment Outcome

2018

Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.

Scandinavian journal of gastroenterology, 2015, Volume: 50, Issue:11

Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bismuth; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Female; Humans; Logistic Models; Male; Middle Aged; Organometallic Compounds; Salicylates; Tertiary Care Centers; Treatment Outcome

2015